[Clinical observations on the use of p-bis-(beta-chloroethyl) aminophenylalanine in the treatment of reticulosarcomatosis and lymphosarcomatosis].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D009369:Neoplasms; D010649:Phenylalanine / Q000031:analogs & derivatives; D012509:Sarcoma
D000970:Antineoplastic Agents; D010649:Phenylalanine
CYTOTOXIC DRUGS/therapeutic use; LYMPHOSARCOMA/therapy; PHENYLALANINE/related compounds; SARCOMA, RETICULUM CELL/therapy
Osservazioni cliniche sull'impiego della DL-p-bis (beta-cloroetil) aminofenilalanina nella terapia delle reticolosarcomatosi e linfosarcomatosi.